<< Read Full Article
<< Read Full Article
Sanofi's Prospects Get Leaner
- Loading Comments...
Shares of Sanofi-Aventis (SNY Quote) skidded Thursday, one day after the company suffered a major setback for its weight-loss drug Zimulti.
A panel of outside advisers to the Food and Drug Administration recommended unanimously Wednesday that the agency reject the obesity drug because Zimulti's risks were greater than its potential benefits of reducing weight in obese patients.
The medical experts said the company had failed to provide enough proof in its clinical trials about the drug's safety, especially its risk of triggering suicidal thinking. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,441.12 | 1,109.18 | 2,206.91 | 35.96 |
Oil *
73.55
|
|
DOWN
10.88
|
UP
1.25
|
UP
5.86
|
DOWN
0.07
|
10 Yr
3.60%
SPDR Gold
111.59
|
|
-0.10%
|
+0.11%
|
+0.27%
|
-0.19%
|
Data delayed 20 minutes |
Connect with TheStreet